Debt-to-equity of Q32 Bio Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Q32 Bio Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Q32 Bio Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -1118%, a 131% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Q32 Bio Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -1118% -633% -131% 30 Sep 2025
Q2 2025 4330% +4472% 30 Jun 2025
Q1 2025 648% +723% 31 Mar 2025
Q4 2024 346% +389% 31 Dec 2024
Q3 2024 -485% -450% -1286% 30 Sep 2024
Q2 2024 -142% -43% -43% 30 Jun 2024
Q1 2024 -75% -182% -170% 31 Mar 2024
Q4 2023 -43% -76% -230% 31 Dec 2023
Q3 2023 -35% -56% -268% 30 Sep 2023
Q2 2023 -99% -118% -631% 30 Jun 2023
Q1 2023 107% +89% +500% 31 Mar 2023
Q4 2022 33% +15% +84% 31 Dec 2022
Q3 2022 21% 0% +1.7% 30 Sep 2022
Q2 2022 19% -6% -24% 30 Jun 2022
Q1 2022 18% -11% -39% 31 Mar 2022
Q4 2021 18% -14% -44% 31 Dec 2021
Q3 2021 21% -7% -26% 30 Sep 2021
Q2 2021 25% -1% -2.9% 30 Jun 2021
Q1 2021 29% +7% +31% 31 Mar 2021
Q4 2020 32% +9% +38% 31 Dec 2020
Q3 2020 28% +2% +7.1% 30 Sep 2020
Q2 2020 25% -2% -6% 30 Jun 2020
Q1 2020 22% -5% -18% 31 Mar 2020
Q4 2019 23% -11% -33% 31 Dec 2019
Q3 2019 26% -25% -49% 30 Sep 2019
Q2 2019 27% 30 Jun 2019
Q1 2019 27% 31 Mar 2019
Q4 2018 34% 31 Dec 2018
Q3 2018 51% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.